CA Stock MarketDetailed Quotes
NGEN NervGen Pharma Corp
- 2.280
- +0.040+1.79%
15min DelayMarket Closed Nov 19 16:00 ET
160.30MMarket Cap-6000P/E (TTM)
2.300High2.210Low19.52KVolume2.250Open2.240Pre Close44.30KTurnover3.98052wk High0.03%Turnover Ratio70.31MShares1.58052wk Low-0.38EPS TTM132.87MFloat Cap3.980Historical HighLossP/E (Static)58.28MShs Float0.800Historical Low-0.38EPS LYR4.02%Amplitude--Dividend TTM17.40P/B1Lot Size--Div YieldTTM
About NervGen Pharma Corp Company
NervGen Pharma Corp principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291, and NVG-300.
Company Profile
SymbolNGEN
Company NameNervGen Pharma Corp
Founded2017
MarketTSX
Employees11
Fiscal Year Ends12-31
Address112-970 Burrard Street Unit 1290
CityVancouver
CountryCAN
Zip CodeV6Z 2R4
Phone+1 778 731-1711
Websitehttps://www.nervgen.com
Company Executives
- Name
- Position
- Salary
- Michael Kelly
- Director, President and Chief Executive Officer
- --
- Dr. Daniel D. Mikol, M.D.
- Chief Medical Officer
- --
- William J. Adams
- Chief Financial Officer and Corporate Secretary
- --
- Glenn A. Ives
- Chairman of the Board
- --
- Neil Klompas, C.A.,C.P.A.
- Director
- --
- Dr. Adam H. Rogers, M.D.
- Director
- --
- Gianni Ruffolo
- Independent Director
- --
- Brian Eric Bayley
- Independent Director
- --
- Dr. Harold M. Punnett
- Independent Director
- --
- Krista L. McKerracher
- Independent Director
- --
- John Craig Thompson
- Independent Director
- --
- Dr. Randall E. Kaye,M.D.
- Independent Director
- --
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data